Defending $300k/Year Orphan Drug Pricing to National Health Ministries
Health ministries resist high-cost rare disease treatments. Discover how market access directors prove Quality-Adjusted Life Years (QALY) and offset hospitalization costs.
Amit KasliwalCEO & Founder, Dehurdle
March 14, 20234 min read
The Health Economics Offset Defense
Recommended Spoken Script
"While the annual therapy cost is €280,000, this one-time precision enzyme replacement eliminates the €450,000 in annual emergency ICU hospitalizations and permanent organ damage previously suffered by each patient, generating a net lifetime saving of €1.2M per treated individual for the national health budget."
The 2-Minute Practice Drill
2-Minute Spoken Drill
The 2-Minute Practice Drill
Practice orphan drug reimbursement negotiations in Dehurdle.
Follow Dehurdle on Google
Add Dehurdle to your Google Preferred Sources to see our playbooks in your AI Overviews and Google Search.